<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Aging Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1663-4365</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400911</article-id><article-id pub-id-type="pmc">PMC12092387</article-id><article-id pub-id-type="doi">10.3389/fnagi.2025.1577256</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Development and validation of a nomogram to predict the risk of post-stroke complex regional pain syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Qian</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/2976233/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Qing</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Jianling</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Xuanling</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Aiguo</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/2776462/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Luo</surname><given-names>Shuxiong</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/3040354/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Tuina, Dongguan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine</institution>, <addr-line>Dongguan</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Acupuncture and Moxibustion, Dongguan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine</institution>, <addr-line>Dongguan</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Massimo Ralli, Sapienza University of Rome, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Dongwei Sun, University of California, Riverside, United States</p><p>Mengyuan Ding, Harvard University, United States</p></fn><corresp id="c001">*Correspondence: Shuxiong Luo, <email>289611595@qq.com</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>17</volume><elocation-id>1577256</elocation-id><history><date date-type="received"><day>15</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>16</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Xie, Song, Deng, Cheng, Xue and Luo.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Xie, Song, Deng, Cheng, Xue and Luo</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Objective</title><p>This study aims to assess risk factors and build a nomogram model to facilitate the early recognition of post-stroke complex regional pain syndrome (CRPS).</p></sec><sec><title>Methods</title><p>A total of 587 stroke patients admitted to Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine from September 2021 to October 2024 were initially included in this study. After exclusions, 376 patients were selected. Among these, there were 90 patients with post-stroke CRPS, while the non-stroke CRPS group consisted of 286 patients. Feature selection and optimization to generate the predictive model and nomogram were performed using LASSO regression and multivariable logistic regression analysis. We also utilized calibration plots, receiver operating characteristic (ROC) curves, decision curves (DCA), and clinical impact curves (CIC) for model validation.</p></sec><sec><title>Results</title><p>LASSO regression analysis and multivariate logistic regression identified gender, age, NIHSS score, cervical spondylosis, sleep disorders, fasting blood glucose (FBG), and albumin (ALB) as significant predictors. The nomogram model showcased reliable predictive effectiveness, achieving an area under the curve (AUC) of 0.858 (95% CI, 0.801&#x02013;0.915). Both DCA and CIC demonstrated that the nomogram model holds substantial clinical utility.</p></sec><sec><title>Conclusion</title><p>This study has developed a novel predictive model for post-stroke CRPS, providing a valuable tool to facilitate the early detection of high-risk patients in a clinical environment.</p></sec></abstract><kwd-group><kwd>post-stroke complex regional pain syndrome</kwd><kwd>stroke</kwd><kwd>nomogram</kwd><kwd>prediction model</kwd><kwd>LASSO</kwd></kwd-group><funding-group><funding-statement>The authors declare that financial support was received for the research and/or publication of this article. This study was supported by the Research Project of the Guangdong Provincial Administration of Traditional Chinese Medicine (Grant No. 202404252256449440) and another grant (Grant No. 20231366) from the same administration.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="2"/><equation-count count="0"/><ref-count count="46"/><page-count count="11"/><word-count count="6203"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Neuroinflammation and Neuropathy</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>1 Introduction</title><p>Complex regional pain syndrome (CRPS) is a complex pain disorder marked by autonomic dysfunction and inflammation (<xref rid="B8" ref-type="bibr">Bruehl, 2015</xref>). Evidence suggests that post-stroke CRPS predominantly manifests as Type I CRPS (<xref rid="B27" ref-type="bibr">Merskey, 1986</xref>), which is also known as shoulder-hand syndrome (SHS).</p><p>At present, research on post-stroke CRPS is sparse among scholars both domestically and internationally (<xref rid="B11" ref-type="bibr">Eldufani et al., 2020</xref>; <xref rid="B25" ref-type="bibr">Marinus et al., 2011</xref>; <xref rid="B36" ref-type="bibr">Taylor et al., 2021</xref>; <xref rid="B39" ref-type="bibr">Urits et al., 2018</xref>). The definitions, pathophysiology, treatment, and prognosis of post-stroke CRPS remain subjects of controversy, and protocols for preventing post-stroke CRPS have not yet been established. Findings suggest that the rate of post-stroke CRPS can be as high as 50.0% (<xref rid="B14" ref-type="bibr">Han et al., 2014</xref>; <xref rid="B20" ref-type="bibr">Katsura et al., 2022</xref>; <xref rid="B22" ref-type="bibr">Kim et al., 2020</xref>), making it one of the prevalent complications of stroke and a significant factor contributing to disability in stroke patients. It primarily manifests as restricted movement and pain in the shoulder, hand, and wrist, along with symptoms such as allodynia, swelling, changes in sweating, elevated temperature, and, in severe cases, irreversible loss of hand function (<xref rid="B16" ref-type="bibr">Harden et al., 2013</xref>). This condition markedly influences patients&#x02019; physical and psychological health and, subsequently, their quality of life, leading to increased disability and higher public healthcare costs. Research has reported that early treatment can lower the likelihood of developing CRPS (<xref rid="B23" ref-type="bibr">Kondo et al., 2001</xref>). Therefore, timely recognition of high-risk populations for post-stroke CRPS, combined with proactive and effective preventive interventions, could lead to reduced hospital stays and treatment costs while improving patients&#x02019; quality of life (<xref rid="B12" ref-type="bibr">Elsamadicy et al., 2018</xref>).</p><p>Prior meta-analyses have shown that factors linked to the onset of post-stroke CRPS include being female, left-sided hemiparesis, shoulder subluxation, spasticity, the upper limb&#x02019;s distal Brunnstrom stage, and scoring low on the Barthel index (<xref rid="B35" ref-type="bibr">Su et al., 2021</xref>). However, there are currently no studies that comprehensively assess various risk factors for post-stroke CRPS using a nomogram model, which fails to meet clinical needs. Therefore, developing a risk prediction model for post-stroke CRPS specifically tailored to stroke patients holds significant clinical importance. A nomogram is a graphical tool composed of line segments representing various predictive variables. It offers several advantages, including practicality, ease of interpretation, and effective and accurate predictive capabilities, providing clinicians with an intuitive prediction tool that facilitates its use in clinical practice (<xref rid="B6" ref-type="bibr">Balachandran et al., 2015</xref>).</p></sec><sec sec-type="materials|methods" id="S2"><title>2 Materials and methods</title><sec id="S2.SS1"><title>2.1 Study design and participants</title><p>We conducted a retrospective analysis, gathering data from a total of 587 individuals who had suffered strokes and were subsequently admitted to the Rehabilitation Department of Dongguan Hospital, Guangzhou University of Traditional Chinese Medicine. This data collection period spanned from September 2021 to October 2024. The following inclusion criteria were established: (1) adhering to the diagnostic criteria for cerebrovascular disease outlined in the Fourth National Conference (<xref rid="B10" ref-type="bibr">Chinese Medical Association Neurology Branch, 2019</xref>) and diagnosed using CT and verified by MRI scans; (2) an age span of 18 to 90 years. The exclusion criteria comprised: (1) individuals with transient ischemic attacks; (2) individuals with a history of upper limb surgery; (3) patients with other severe comorbid conditions, including but not limited to malignant tumors, severe cardiovascular diseases, severe liver and biliary diseases, renal failure; (4) patients with significantly missing required case data; (5) patients who had experienced fever or infection in the past two weeks.</p><p>Finally, 376 stroke patients were enrolled. They were classified during their hospitalization into the training cohort (264 cases) and validation cohort (112 cases) at a ratio of 7:3. Discrimination was performed to determine whether the stroke patients had CRPS based on the diagnostic criteria published in 2024 (<xref rid="B1" ref-type="bibr">Abd-Elsayed et al., 2024</xref>). This study was conducted in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of Dongguan Hospital, Guangzhou University of Traditional Chinese Medicine (PJ [2025] No.2). Since this retrospective observational study did not infringe upon patient privacy and posed no risk to patient safety, informed consent was waived by the Ethics Committee. To protect patient confidentiality, the data from this study will not be made publicly available.</p></sec><sec id="S2.SS2"><title>2.2 Clinical data acquisition</title><p>Predictive variables for patients with post-stroke CRPS were identified through an analysis of existing literature and clinical experience. Data were carefully gathered from the electronic medical records of the patients, which included: (1) Demographic information: Gender, age, income (low income, middle income, high income), smoking history, alcohol consumption history, medical history (hypertension, diabetes, coronary heart disease, hyperlipidemias, cervical spondylosis), previous stroke, previous shoulder diseases (chronic shoulder pain, shoulder trauma),type of stroke (hemorrhagic, infarction, or a combination of both), lesion location (cerebral cortex, cerebellum, thalamus, basal ganglia, brainstem), affected side of hemiplegia (left side, right side), muscle strength of the affected upper limb (0&#x02013;3 levels, 4&#x02013;5 levels), treatment (surgical treatment, conservative treatment), sleep disorders, and comorbid depression. (2) Laboratory indicators: White blood cells (WBC), hemoglobin (HBG), neutrophil percentage (NEUT%), C-reactive protein (CRP), prealbumin (PAB), albumin (ALB), uric acid (UA), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), and D-dimer. (3) Barthel Index: This index was utilized to evaluate the patients&#x02019; activities of daily living (ADL). It comprises 10 aspects and categorizes scores into three groups: independent (100 points), essential self-care (61 to 99 points), and poor self-care ability (below 60 points). A higher score indicates greater independence and lower dependence. The primary outcome measured was whether or not the patient developed post-stroke CRPS. (4) The National Institutes of Health Stroke Scale (NIHSS) consists of 15 items, with a total score ranging from 0 to 42. Higher scores indicate more severe neurological impairment. The scores are classified as follows: a score of less than 5 indicates mild impairment; 5 to 15, moderate impairment; and 16 or greater, severe impairment.</p></sec><sec id="S2.SS3"><title>2.3 Statistical analysis</title><p>Statistical analysis was primarily performed using R software (version 4.2.1) and SPSS software (IBM version 26.0). Descriptive statistics were conducted on 376 participants. Summarize categorical data using frequency (<italic>n</italic>) and percentage (%). Continuous variables with a normal distribution were expressed as mean &#x000b1; standard deviation (SD), while continuous variables with a non-normal distribution were expressed as the median and interquartile range. Categorical variables are compared using chi-square analysis, while continuous variables are analyzed using the Mann-Whitney test.</p><p>The creation and application of the nomogram model involve three main steps. First, to mitigate multicollinearity and overfitting while simplifying the model and selecting variables, LASSO regression was employed, running 10-fold cross-validation to normalize the included variables and identify the optimal lambda value (<xref rid="B31" ref-type="bibr">Sauerbrei et al., 2007</xref>). Seven non-zero coefficients were used to determine the independent predictive features (<xref rid="B4" ref-type="bibr">Alhamzawi and Ali, 2018</xref>). Second, statistically significant variables were chosen to build the nomogram model through multivariable logistic regression analysis (<xref rid="B35" ref-type="bibr">Su et al., 2021</xref>). Third, the effectiveness of the nomogram was assessed through calibration plots and receiver operating characteristic (ROC), where the Area Under the ROC Curve (AUROC) value exceeding 0.7 demonstrates strong discrimination by the model. Decision curve analysis (DCA) and clinical impact curves (CIC) were employed to assess the clinical utility of the nomogram (<xref rid="B41" ref-type="bibr">Vickers et al., 2008</xref>).</p></sec></sec><sec sec-type="results" id="S3"><title>3 Results</title><sec id="S3.SS1"><title>3.1 Study flow diagram</title><p>The flowchart is illustrated in <xref rid="F1" ref-type="fig">Figure 1</xref>. Out of the 587 stroke patients, 211 did not meet the inclusion criteria. Ultimately, a total of 376 individuals participated in the study.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Flowchart.</p></caption><graphic xlink:href="fnagi-17-1577256-g001" position="float"/></fig></sec><sec id="S3.SS2"><title>3.2 Patient characteristics</title><p>The study included 376 stroke patients, of whom 286 (76.1%) were diagnosed with non-post-stroke CRPS, and 90 (23.9%) were diagnosed with post-stroke CRPS. <xref rid="T1" ref-type="table">Table 1</xref> displays the differences between the two groups in terms of demographic data, clinical features, relevant scoring scales, and laboratory indicators.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Descriptive and other characteristics of participants in training and validation group.</p></caption><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Variables</td><td valign="top" align="center" colspan="4" style="color:#ffffff;background-color: #7f8080;" rowspan="1">Training group</td><td valign="top" align="center" colspan="4" style="color:#ffffff;background-color: #7f8080;" rowspan="1">Validation group</td></tr></thead><tbody><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1"/><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold>Total (<italic>n</italic> = 264)</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold>Non-post CRPS (<italic>n</italic> = 207)</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold>Post-stroke CRPS (<italic>n</italic> = 57)</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold><italic>P</italic>-value</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold>Total (<italic>n</italic> = 112)</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold>Non-post CRPS (<italic>n</italic> = 79)</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold>Post-stroke CRPS (<italic>n</italic> = 33)</bold>
</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<bold><italic>P</italic>-value</bold>
</td></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Demographics</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">62.47 &#x000b1; 2.28</td><td valign="top" align="center" rowspan="1" colspan="1">61.28 &#x000b1; 12.46</td><td valign="top" align="center" rowspan="1" colspan="1">66.82 &#x000b1; 1.60</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.002</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">63 (52 &#x000b1; 70)</td><td valign="top" align="center" rowspan="1" colspan="1">60.48 &#x000b1; 12.11</td><td valign="top" align="center" rowspan="1" colspan="1">64.55 &#x000b1; 10.37</td><td valign="top" align="center" rowspan="1" colspan="1">0.095</td></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Gender, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">182 (68.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">154 (74.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (49.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.001</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">79 (70.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">63 (79.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (48.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.001</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">82 (31.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">53 (25.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (50.9%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">33 (29.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (20.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (51.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Income, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low income</td><td valign="top" align="center" rowspan="1" colspan="1">63 (23.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (23.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (24.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.541</td><td valign="top" align="center" rowspan="1" colspan="1">31 (27.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (29.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (24.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.209</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Middle income</td><td valign="top" align="center" rowspan="1" colspan="1">160 (60.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">129 (62.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">31 (54.4%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">64 (57.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">47 (59.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (51.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High income</td><td valign="top" align="center" rowspan="1" colspan="1">41 (15.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (14%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (21.1%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">17 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (11.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (24.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Medical history</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">222 (84.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">175 (84.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">47 (82.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.703</td><td valign="top" align="center" rowspan="1" colspan="1">88 (78.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">64 (81%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (72.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.330</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">99 (37.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">30 (52.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.008</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">38 (33.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (35.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (30.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.600</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CHD, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (9.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (8.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (10.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.670</td><td valign="top" align="center" rowspan="1" colspan="1">14 (12.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (10.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (18.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.389</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hyperlipidemias, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">61 (23.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (23.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (21.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.678</td><td valign="top" align="center" rowspan="1" colspan="1">17 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cervical spondylosis, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">30 (11.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (5.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (31.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.001</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">11 (9.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (8.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.857</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Previous stroke, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">33 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (10.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (19.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.080</td><td valign="top" align="center" rowspan="1" colspan="1">19 (17%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (21.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.439</td></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Previous shoulder disease, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chronic shoulder pain</td><td valign="top" align="center" rowspan="1" colspan="1">6 (2.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (1.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.030</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">2 (1.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.001</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Shoulder trauma</td><td valign="top" align="center" rowspan="1" colspan="1">8 (3%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (1.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (8.8%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4 (3.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Smoking, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">82 (31.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">64 (30.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (31.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.924</td><td valign="top" align="center" rowspan="1" colspan="1">32 (28.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (25.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (36.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.238</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alcohol drinking, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">67 (25.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">53 (25.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (24.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.873</td><td valign="top" align="center" rowspan="1" colspan="1">23 (20.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (20.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (21.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.909</td></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Clinical features</bold>
</td></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Types of stroke, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Infarction</td><td valign="top" align="center" rowspan="1" colspan="1">200 (75.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">149 (72.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">51 (89.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.022</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">84 (75%)</td><td valign="top" align="center" rowspan="1" colspan="1">55 (69.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (87.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.084</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hemorrhage</td><td valign="top" align="center" rowspan="1" colspan="1">58 (22.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">53 (25.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (8.8%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">24 (21.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (26.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Infarction combined with hemorrhage</td><td valign="top" align="center" rowspan="1" colspan="1">6 (2.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4 (3.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Location of occlusion, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cerebral cortex</td><td valign="top" align="center" rowspan="1" colspan="1">96 (36.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">74 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (38.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.907</td><td valign="top" align="center" rowspan="1" colspan="1">39 (34.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (35.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.782</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cerebellum</td><td valign="top" align="center" rowspan="1" colspan="1">11 (4.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (4.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.5%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">6 (5.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Thalamus</td><td valign="top" align="center" rowspan="1" colspan="1">24 (9.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (8.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (10.5%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">9 (8%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (7.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Basal ganglia</td><td valign="top" align="center" rowspan="1" colspan="1">101 (38.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">82 (39.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (33.3%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">39 (34.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (36.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (30.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Brainstem</td><td valign="top" align="center" rowspan="1" colspan="1">32 (12.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (11.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (14%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">13 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (16.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (16.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Hemiplegic limbs, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Left</td><td valign="top" align="center" rowspan="1" colspan="1">143 (54.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">108 (52.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (61.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.216</td><td valign="top" align="center" rowspan="1" colspan="1">60 (53.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">37 (46.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (69.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.027</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right</td><td valign="top" align="center" rowspan="1" colspan="1">121 (45.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">99 (47.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (38.6%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">52 (46.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">42 (53.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (30.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>MMT upper, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0&#x02013;3 level</td><td valign="top" align="center" rowspan="1" colspan="1">128 (48.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">104 (50.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (42.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.276</td><td valign="top" align="center" rowspan="1" colspan="1">61 (54.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (60.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (39.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.038</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4&#x02013;5 level</td><td valign="top" align="center" rowspan="1" colspan="1">136 (51.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">103 (49.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">33 (57.9%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">51 (45.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">31 (39.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (60.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Treatment, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Surgical treatment</td><td valign="top" align="center" rowspan="1" colspan="1">66 (25%)</td><td valign="top" align="center" rowspan="1" colspan="1">57 (27.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (15.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.070</td><td valign="top" align="center" rowspan="1" colspan="1">27 (24.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (25.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (21.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.643</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Conservative treatment</td><td valign="top" align="center" rowspan="1" colspan="1">198 (75%)</td><td valign="top" align="center" rowspan="1" colspan="1">150 (72.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (84.2%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">85 (75.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">59 (74.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (25.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sleep disorder, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">46 (17.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">31 (15%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (26.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.046</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">25 (22.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (39.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.005</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Comorbid depression, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (9.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (9.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.539</td><td valign="top" align="center" rowspan="1" colspan="1">8 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.908</td></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>NIHSS score, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c; 5</td><td valign="top" align="center" rowspan="1" colspan="1">148 (56.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">109 (52.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (68.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.024</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">52 (46.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">33 (41.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (57.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.128</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5&#x02013;15</td><td valign="top" align="center" rowspan="1" colspan="1">108 (40.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">90 (43.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (31.6%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">55 (49.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">42 (53.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (39.4%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02265; 16</td><td valign="top" align="center" rowspan="1" colspan="1">8 (3%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (3.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">5 (4.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (5.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>ADL, n (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">27 (10.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (8.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (15.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.127</td><td valign="top" align="center" rowspan="1" colspan="1">11 (9.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (8.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.742</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">99&#x02013;61</td><td valign="top" align="center" rowspan="1" colspan="1">157 (59.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">123 (59.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">34 (59.6%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">66 (58.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">47 (59.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (57.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c; 60</td><td valign="top" align="center" rowspan="1" colspan="1">80 (30.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">66 (31.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (24.6%)</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">35 (31.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (31.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (30.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="9" style="background-color: #dcdcdc;" rowspan="1">
<bold>Inspection results</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">White blood cell, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">6.96 &#x000b1; 1.96</td><td valign="top" align="center" rowspan="1" colspan="1">6.91 &#x000b1; 1.90</td><td valign="top" align="center" rowspan="1" colspan="1">7.17 &#x000b1; 2.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.379</td><td valign="top" align="center" rowspan="1" colspan="1">7.46 &#x000b1; 2.25</td><td valign="top" align="center" rowspan="1" colspan="1">6.98 &#x000b1; 1.92</td><td valign="top" align="center" rowspan="1" colspan="1">8.61 &#x000b1; 2.59</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.001</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hemoglobin, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">132.42 &#x000b1; 17.04</td><td valign="top" align="center" rowspan="1" colspan="1">133.05 &#x000b1; 16.63</td><td valign="top" align="center" rowspan="1" colspan="1">130.10 &#x000b1; 18.42</td><td valign="top" align="center" rowspan="1" colspan="1">0.247</td><td valign="top" align="center" rowspan="1" colspan="1">131.30 &#x000b1; 17.52</td><td valign="top" align="center" rowspan="1" colspan="1">130.92 &#x000b1; 15.92</td><td valign="top" align="center" rowspan="1" colspan="1">132.22 &#x000b1; 21.12</td><td valign="top" align="center" rowspan="1" colspan="1">0.722</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NEUT%, median (IQR)</td><td valign="top" align="center" rowspan="1" colspan="1">64.25 (57.83&#x02013;70.28)</td><td valign="top" align="center" rowspan="1" colspan="1">63.7 (57.6&#x02013;69.7)</td><td valign="top" align="center" rowspan="1" colspan="1">66.2 (60.5&#x02013;70.95)</td><td valign="top" align="center" rowspan="1" colspan="1">0.054</td><td valign="top" align="center" rowspan="1" colspan="1">65.5 (58.51&#x02013;70.18)</td><td valign="top" align="center" rowspan="1" colspan="1">64.2 (58.5&#x02013;69.5)</td><td valign="top" align="center" rowspan="1" colspan="1">68.4 (59.39&#x02013;74.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.075</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">C-reactive protein, median (IQR)</td><td valign="top" align="center" rowspan="1" colspan="1">2.23 (1.00&#x02013;5.40)</td><td valign="top" align="center" rowspan="1" colspan="1">2.1 (0.99&#x02013;5.05)</td><td valign="top" align="center" rowspan="1" colspan="1">2.82 (1.01&#x02013;6.79)</td><td valign="top" align="center" rowspan="1" colspan="1">0.217</td><td valign="top" align="center" rowspan="1" colspan="1">2.52 (1.26&#x02013;7.49)</td><td valign="top" align="center" rowspan="1" colspan="1">2.40 (1.22&#x02013;6.40)</td><td valign="top" align="center" rowspan="1" colspan="1">4.15 (1.50&#x02013;9.16)</td><td valign="top" align="center" rowspan="1" colspan="1">0.229</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prealbumin, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">248.53 &#x000b1; 47.58</td><td valign="top" align="center" rowspan="1" colspan="1">250.57 &#x000b1; 42.07</td><td valign="top" align="center" rowspan="1" colspan="1">241.10 &#x000b1; 63.62</td><td valign="top" align="center" rowspan="1" colspan="1">0.184</td><td valign="top" align="center" rowspan="1" colspan="1">240.11 &#x000b1; 40.81</td><td valign="top" align="center" rowspan="1" colspan="1">244.61 &#x000b1; 37.67</td><td valign="top" align="center" rowspan="1" colspan="1">229.30 &#x000b1; 46.35</td><td valign="top" align="center" rowspan="1" colspan="1">0.053</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Albumin, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">40.25 &#x000b1; 4.14</td><td valign="top" align="center" rowspan="1" colspan="1">40.01 &#x000b1; 3.16</td><td valign="top" align="center" rowspan="1" colspan="1">41.13 &#x000b1; 6.53</td><td valign="top" align="center" rowspan="1" colspan="1">0.070</td><td valign="top" align="center" rowspan="1" colspan="1">39.65 &#x000b1; 3.55</td><td valign="top" align="center" rowspan="1" colspan="1">39.85 &#x000b1; 3.10</td><td valign="top" align="center" rowspan="1" colspan="1">39.19 &#x000b1; 4.47</td><td valign="top" align="center" rowspan="1" colspan="1">0.070</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HbA1c, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">6.21 &#x000b1; 1.61</td><td valign="top" align="center" rowspan="1" colspan="1">6.08 &#x000b1; 1.47</td><td valign="top" align="center" rowspan="1" colspan="1">6.67 &#x000b1; 1.97</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.013</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">6.14 &#x000b1; 1.27</td><td valign="top" align="center" rowspan="1" colspan="1">6.01 &#x000b1; 1.18</td><td valign="top" align="center" rowspan="1" colspan="1">6.48 &#x000b1; 1.40</td><td valign="top" align="center" rowspan="1" colspan="1">0.373</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Uric acid, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">355.81 &#x000b1; 97.95</td><td valign="top" align="center" rowspan="1" colspan="1">360.04 &#x000b1; 91.75</td><td valign="top" align="center" rowspan="1" colspan="1">340.46 &#x000b1; 117.39</td><td valign="top" align="center" rowspan="1" colspan="1">0.182</td><td valign="top" align="center" rowspan="1" colspan="1">366.12 &#x000b1; 117.17</td><td valign="top" align="center" rowspan="1" colspan="1">358.69 &#x000b1; 117.25</td><td valign="top" align="center" rowspan="1" colspan="1">383.92 &#x000b1; 116.84</td><td valign="top" align="center" rowspan="1" colspan="1">0.073</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fasting blood glucose, mean &#x000b1; SD</td><td valign="top" align="center" rowspan="1" colspan="1">5.90 &#x000b1; 1.61</td><td valign="top" align="center" rowspan="1" colspan="1">5.59 &#x000b1; 1.19</td><td valign="top" align="center" rowspan="1" colspan="1">7.02 &#x000b1; 2.30</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.001</bold>
</td><td valign="top" align="center" rowspan="1" colspan="1">5.70 &#x000b1; 1.32</td><td valign="top" align="center" rowspan="1" colspan="1">5.48 &#x000b1; 0.99</td><td valign="top" align="center" rowspan="1" colspan="1">6.24 &#x000b1; 1.81</td><td valign="top" align="center" rowspan="1" colspan="1">0.301</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">D-dimer, median (IQR)</td><td valign="top" align="center" rowspan="1" colspan="1">0.44 (0.22&#x02013;0.91)</td><td valign="top" align="center" rowspan="1" colspan="1">0.42 (0.22&#x02013;0.89)</td><td valign="top" align="center" rowspan="1" colspan="1">0.51 (0.28&#x02013;1.05)</td><td valign="top" align="center" rowspan="1" colspan="1">0.064</td><td valign="top" align="center" rowspan="1" colspan="1">0.49 (0.27&#x02013;0.95)</td><td valign="top" align="center" rowspan="1" colspan="1">0.44 (0.22&#x02013;0.76)</td><td valign="top" align="center" rowspan="1" colspan="1">0.57 (0.41&#x02013;1.00)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.005</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p>CHD, coronary heart disease; MMT upper, manual muscle testing (affected upper limb); NIHSS, National Institute of Health Stroke Scale; ADL, activities of daily living; NEUT%, the neutrophil percentage; HbA1c, glycated hemoglobin; IQR, interquartile range; SD, standard deviation. <italic>P</italic>-values less than 0.05 are highlighted in bold.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S3.SS3"><title>3.3 Independent risk factors in the training set</title><p>LASSO regression was carried out to determine the threatening elements linked to the development of CRPS among stroke patients included in the training set. This approach serves as a strong competitor for variable selection in Cox models (<xref rid="B31" ref-type="bibr">Sauerbrei et al., 2007</xref>). Determine the optimal regularization parameter &#x003bb; based on 10-fold cross-validation and minimizing the standard error. The seven most relevant predictive factors were selected from a total of 31 correlated variables. These factors include gender, age, NIHSS score, cervical spondylosis, sleep disorders, FBG, and ALB (see <xref rid="F2" ref-type="fig">Figures 2A, B</xref> for a visual representation of these findings).</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p><bold>(A)</bold> The profile plot shows the LASSO coefficients for 31 features plotted against the log(lambda) sequence. Seven variables were chosen based on the optimal lambda. <bold>(B)</bold> A vertical dashed line is drawn to represent the value determined through 10-fold cross-validation. The optimal adjusted parameter log(&#x003bb;) is displayed on the horizontal axis, while the deviance (binomial deviance) is shown on the vertical axis.</p></caption><graphic xlink:href="fnagi-17-1577256-g002" position="float"/></fig></sec><sec id="S3.SS4"><title>3.4 Prediction model development</title><p>The results of the multivariable logistic regression analysis indicate that gender, age, NIHSS score, cervical spondylosis, sleep disorder, FBG, and ALB are independent predictive factors for post-stroke CRPS (<xref rid="T2" ref-type="table">Table 2</xref>). All seven predictive variables demonstrated significant statistical differences. Therefore, based on these seven factors, a risk nomogram for post-stroke CRPS was developed (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><table-wrap position="float" id="T2"><label>TABLE 2</label><caption><p>Multivariate logistic regression analysis.</p></caption><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Variables</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">OR</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">95% CI</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">
<italic>P</italic>
</td></tr></thead><tbody><tr><td valign="top" align="left" colspan="4" style="background-color: #dcdcdc;" rowspan="1">
<bold>Gender</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">0.413</td><td valign="top" align="center" rowspan="1" colspan="1">0.189&#x0223c;0.906</td><td valign="top" align="center" rowspan="1" colspan="1">0.027</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1">1.044</td><td valign="top" align="center" rowspan="1" colspan="1">1.006&#x0223c;1.082</td><td valign="top" align="center" rowspan="1" colspan="1">0.021</td></tr><tr><td valign="top" align="left" colspan="4" style="background-color: #dcdcdc;" rowspan="1">
<bold>NIHSS score</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5&#x02013;15</td><td valign="top" align="center" rowspan="1" colspan="1">0.436</td><td valign="top" align="center" rowspan="1" colspan="1">0.198&#x0223c;0.964</td><td valign="top" align="center" rowspan="1" colspan="1">0.040</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cervical spondylosis</td><td valign="top" align="center" rowspan="1" colspan="1">13.447</td><td valign="top" align="center" rowspan="1" colspan="1">4.764&#x0223c;37.954</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sleep disorder</td><td valign="top" align="center" rowspan="1" colspan="1">2.635</td><td valign="top" align="center" rowspan="1" colspan="1">1.098&#x0223c;6.324</td><td valign="top" align="center" rowspan="1" colspan="1">0.030</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Albumin</td><td valign="top" align="center" rowspan="1" colspan="1">1.132</td><td valign="top" align="center" rowspan="1" colspan="1">1.036&#x0223c;1.237</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FBG</td><td valign="top" align="center" rowspan="1" colspan="1">1.739</td><td valign="top" align="center" rowspan="1" colspan="1">1.368&#x0223c;2.212</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr></tbody></table></table-wrap><fig position="float" id="F3"><label>FIGURE 3</label><caption><p>Nomogram for predicting CRPS in post-stroke patients.</p></caption><graphic xlink:href="fnagi-17-1577256-g003" position="float"/></fig></sec><sec id="S3.SS5"><title>3.5 Validation of the nomogram</title><p>The ROC curve served as a tool for assessing the model&#x02019;s predictive performance. The AUROC was 0.858 in the training set and 0.740 in the validation set (<xref rid="F4" ref-type="fig">Figures 4A, B</xref>), indicating that the nomogram prediction model demonstrates good predictive capability. The Hosmer&#x02013;Lemeshow goodness-of-fit test was employed to evaluate the calibration of the predictive model, and the calibration curve (<xref rid="F5" ref-type="fig">Figures 5A, B</xref>) illustrated a strong correlation between the predicted probabilities and the actual occurrence of post-stroke CRPS in both the validation and training datasets.</p><fig position="float" id="F4"><label>FIGURE 4</label><caption><p>The ROC curve for the nomogram predicting post-stroke CRPS <bold>(A)</bold>. In the training set <bold>(A)</bold>, the AUC was 0.858 (95% CI: 0.801&#x02013;0.915). When a cutoff point was set at a risk probability of 0.180, the specificity and sensitivity of the predicted results were 77.3% and 80.7%, respectively. In the validation set presented in <bold>(B)</bold>, the AUC was 0.740 (95% CI: 0.636&#x02013;0.844), with a threshold of 0.099, a specificity of 0.633, and a sensitivity of 0.818.</p></caption><graphic xlink:href="fnagi-17-1577256-g004" position="float"/></fig><fig position="float" id="F5"><label>FIGURE 5</label><caption><p>Calibration curve for the post-stroke CRPS nomogram <bold>(A,B)</bold>. The diagonal dashed line signifies perfect prediction by the optimal model. The proximity of the red solid line to this dashed line indicates the model&#x02019;s predictive performance; the closer they are, the more accurate the predictions.</p></caption><graphic xlink:href="fnagi-17-1577256-g005" position="float"/></fig></sec><sec id="S3.SS6"><title>3.6 Clinical efficacy of the nomogram</title><p>We performed DCA to assess the clinical applicability of our nomogram. The DCA curves indicate that within a reasonable range of threshold probabilities, the nomogram model can provide clinical net benefit for patients in both the training group and the validation group (<xref rid="F6" ref-type="fig">Figures 6A, B</xref>). Building on this, the CIC was plotted (<xref rid="F7" ref-type="fig">Figures 7A, B</xref>) to assess the model&#x02019;s clinical impact, showing that when the risk threshold exceeds 0.80, the number of positive events is closely aligned with the actual incidence of the condition.</p><fig position="float" id="F6"><label>FIGURE 6</label><caption><p>Decision curve analysis (DCA) for the post-stroke CRPS nomogram prediction <bold>(A,B)</bold>. The <italic>y</italic>-axis measures the net benefit obtained from using the model. The red line in the figure represents the clinical diagnostic model for post-stroke CRPS. In contrast, the black horizontal line (None line) and the gray diagonal line (All line) represent the extreme cases of &#x0201c;no intervention&#x0201d; and &#x0201c;all intervention,&#x0201d; respectively.</p></caption><graphic xlink:href="fnagi-17-1577256-g006" position="float"/></fig><fig position="float" id="F7"><label>FIGURE 7</label><caption><p>Clinical impact curve (CIC) analysis for the post-stroke CRPS nomogram prediction <bold>(A,B)</bold>. The <italic>y</italic>-axis represents the number of individuals at risk. The red line indicates the predicted number of events occurring for post-stroke CRPS, whereas the red dashed line depicts the actual occurrences.</p></caption><graphic xlink:href="fnagi-17-1577256-g007" position="float"/></fig></sec></sec><sec sec-type="discussion" id="S4"><title>4 Discussion</title><p>The etiology of post-stroke CRPS is complex, involving multiple factors, including neurological, circulatory, inflammatory, and psychological aspects. Manifestations include autonomic disturbances (such as skin temperature changes, color abnormalities, and sweating irregularities), sensory issues (pain and allodynia), and motor impairments (such as paralysis, tremors, and dystonia) (<xref rid="B7" ref-type="bibr">Borchers and Gershwin, 2017</xref>).</p><p>In most cases, only about one-fifth of patients are able to fully return to their previous level of regular activity (<xref rid="B26" ref-type="bibr">Matayoshi et al., 2009</xref>; <xref rid="B28" ref-type="bibr">Misidou and Papagoras, 2019</xref>), and this can even lead to irreversible permanent disability, serving as a barrier to rehabilitation and severely affecting patients&#x02019; quality of life. To date, there have been only a handful of research projects that have documented and reported on the various risk factors that are linked to the development of post-stroke CRPS (<xref rid="B21" ref-type="bibr">Katsura et al., 2024</xref>; <xref rid="B43" ref-type="bibr">Yu et al., 2023</xref>). To address this gap, we collected common clinical-related data variables and laboratory findings to establish a diagnostic prediction model, ultimately developing a simplified equation. The results indicate that a composite index of gender, age, NIHSS scores, cervical spondylosis, sleep disorders, FBG, and ALB demonstrates good predictive capability for the occurrence of post-stroke CRPS. As a result, this combined index may serve as a valuable asset that could significantly aid in the timely detection of post-stroke CRPS.</p><p>The age range for cases of post-stroke CRPS primarily falls between 45 and 75 years, with a common prevalence among individuals aged 56 to 65 (<xref rid="B15" ref-type="bibr">Hannan et al., 2013</xref>). Research conducted in the past has shown that age constitutes a significant and independent risk factor for the development of this condition (<xref rid="B44" ref-type="bibr">Zhang et al., 2004</xref>), with older individuals being more susceptible to developing CRPS. This could potentially be associated with the physiological alterations that take place in the skeletal structure, joints, and nervous system as individuals age. Additionally, regarding gender, it is noteworthy that our findings are inconsistent with those of <xref rid="B40" ref-type="bibr">van Velzen et al. (2019)</xref>. The differences in sample size and the generally higher incidence of stroke in males compared to females (<xref rid="B9" ref-type="bibr">Carcel et al., 2020</xref>) may be the main reasons for this discrepancy. The underlying mechanisms are still unclear and require further investigation.</p><p>NIHSS score is a reliable indicator for assessing the severity of neurological impairment in stroke patients. Given the close association between neurological dysfunction and the development of post-stroke CRPS, existing studies have shown a positive correlation between NIHSS scores and the degree of neurological damage (<xref rid="B42" ref-type="bibr">Wang et al., 2025</xref>). Thus, stroke patients with higher NIHSS scores are more likely to develop CRPS.</p><p>Research has indicated that cervical spondylosis ought to be regarded as a potential risk factor for post-stroke CRPS (<xref rid="B34" ref-type="bibr">Steinbrocker, 1947</xref>). We propose that cervical spondylosis may influence the risk of developing CRPS through neural, vascular, and muscular pathways. Firstly, adverse neural stimulation can produce abnormal discharges, leading to persistent transmission of pain signals, which subsequently results in soft tissue spasms around the shoulder joint. Additionally, decreased peripheral nerve nourishment and blood circulation, along with abnormal vasodilation or vasoconstriction, can lead to localized hypoxia and an increase in pro-inflammatory substances (<xref rid="B29" ref-type="bibr">Parkitny et al., 2013</xref>), resulting in persistent pain, alterations in the temperature and color of skin, and swelling (<xref rid="B3" ref-type="bibr">Albrecht et al., 2006</xref>). Therefore, early diagnosis may be beneficial, and to ensure reliability, it will be essential to conduct further clinical research involving a more significant number of participants and data collected from multiple centers in the future.</p><p>Previous studies have found that stroke and sleep disturbances frequently coexist (<xref rid="B33" ref-type="bibr">Sonmez and Karasel, 2019</xref>), with one report indicating that 78% of stroke patients experience varying degrees of sleep disorders (<xref rid="B30" ref-type="bibr">Pasic et al., 2011</xref>). Additionally, some research has clearly shown that sleep problems are frequently observed in individuals suffering from shoulder injuries following a stroke (<xref rid="B2" ref-type="bibr">Al Battat et al., 2023</xref>; <xref rid="B24" ref-type="bibr">K&#x000fc;&#x000e7;&#x000fc;kdeveci et al., 1996</xref>). A cohort study by <xref rid="B45" ref-type="bibr">Zhang et al. (2022)</xref> explored the effect of sleep disruptions on neurological functional outcomes after stroke, revealing a positive correlation between poor neurological function and sleep disturbances. Our study observed that sleep disturbances are an important predictive factor for the occurrence of CRPS following stroke. They can affect the autonomic nervous system, leading to sympathetic nerve dysfunction (<xref rid="B19" ref-type="bibr">Kato et al., 2000</xref>; <xref rid="B37" ref-type="bibr">Tobaldini et al., 2017</xref>), which in turn increases the risk of CRPS after stroke. Furthermore, sleep disturbances can trigger a series of inflammatory responses and oxidative stress, further damaging the nervous system (<xref rid="B5" ref-type="bibr">Atrooz and Salim, 2020</xref>) and significantly increasing the likelihood of CRPS in stroke patients.</p><p>Our study indicates that patients with post-stroke CRPS exhibit elevated fasting blood glucose (FBG) levels, with logistic regression modeling yielding an odds ratio (OR) of 1.739, indicating that FBG represents a significant risk factor for the development of the disease. One of the typical symptoms of post-stroke CRPS is pain. Studies have shown (<xref rid="B18" ref-type="bibr">Hok et al., 2024</xref>) that individual differences in spontaneous pain intensity in post-stroke CRPS are influenced by how insulin affects the resting-state functional connectivity (rsFC) of the prefrontal cortex. Insulin not only influences blood glucose levels but also alters neural network activity by regulating neurotransmitter release and affecting synaptic plasticity (<xref rid="B32" ref-type="bibr">Schwartz et al., 2024</xref>). Changes in FBG and insulin levels reflect the body&#x02019;s response to metabolic load. Therefore, correcting glucose dysregulation may help achieve beneficial effects on the central nervous system, playing a crucial role in predicting CRPS in patients following a stroke. Continued research is needed to verify this potential mechanism.</p><p>We have innovatively discovered that albumin (ALB) can serve as a new independent predictive factor for post-stroke CRPS. Albumin levels are indicative of the body&#x02019;s nutritional status; a decrease in albumin levels can catalyze muscle atrophy (<xref rid="B13" ref-type="bibr">Erdo&#x0011f;an et al., 2024</xref>; <xref rid="B17" ref-type="bibr">He et al., 2024</xref>; <xref rid="B38" ref-type="bibr">Tomata et al., 2022</xref>), leading to a loss of the &#x0201c;muscle pump&#x0201d; function (<xref rid="B46" ref-type="bibr">Zorowitz et al., 1996</xref>), which results in motor dysfunction and venous return obstruction. This can consequently cause swelling and pain in the hemiplegic upper limb, raising the possibility of post-stroke CRPS development.</p><p>Based on these results, we created a nomogram prediction model that provides a potential theoretical reference for assessing the risk of CRPS in patients following a stroke.</p></sec><sec sec-type="conclusion" id="S5"><title>5 Conclusion</title><p>In this study, we identified significant correlations between gender, age, NIHSS scores, cervical spondylosis, sleep disorders, FBG, and ALB with the incidence of post-stroke CRPS. These predictive factors are readily available in clinical settings. Our simplified nomogram can assist clinicians in the early identification of stroke patients prone to developing CRPS, allowing for the initiation of empirical treatment to prevent or halt the progression of post-stroke CRPS. To validate the effectiveness of this new nomogram model, future large-scale prospective studies utilizing comprehensive data from multiple centers will be necessary.</p></sec><sec id="S6"><title>6 Limitations</title><p>This study has certain limitations. Primarily, This is a single-center retrospective study, where both training and validation cohorts are derived from the same medical center, potentially limiting the model&#x02019;s generalizability. Additionally, the study&#x02019;s sample size is limited, necessitating future multicenter, prospective studies with larger cohorts to validate the model&#x02019;s accuracy. Second, due to the historical data analysis nature of our study, data on sleep disturbance scores were lacking, preventing a more detailed analysis of the types and severity of sleep disturbances. Third, this study did not consider all possible risk factors and did not collect data on these factors, which may lead to bias in the results.</p></sec></body><back><ack><p>We thank the staff of the Rehabilitation Department at Dongguan Hospital affiliated with Guangzhou University of Chinese Medicine.</p></ack><sec sec-type="data-availability" id="S7"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec sec-type="ethics-statement" id="S8"><title>Ethics statement</title><p>The studies involving humans were approved by the Ethics Committee of Dongguan Hospital, Guangzhou University of Traditional Chinese Medicine (PJ [2025] No.2). The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x02019; legal guardians/next of kin because Patients were exempt from providing consent because this project was a retrospective observational study that did not infringe on patient privacy and posed no risk to patient safety. The data from this study will not be made public to protect patient confidentiality.</p></sec><sec sec-type="author-contributions" id="S9"><title>Author contributions</title><p>QX: Data curation, Formal Analysis, Investigation, Methodology, Supervision, Validation, Writing &#x02013; original draft, Writing &#x02013; review and editing. QS: Data curation, Investigation, Validation, Writing &#x02013; original draft, Writing &#x02013; review and editing. JD: Data curation, Project administration, Validation, Writing &#x02013; review and editing. XC: Data curation, Supervision, Validation, Writing &#x02013; original draft. AX: Funding acquisition, Resources, Supervision, Writing &#x02013; review and editing. SL: Funding acquisition, Project administration, Resources, Supervision, Writing &#x02013; review and editing.</p></sec><sec sec-type="COI-statement" id="S11"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="S12"><title>Generative AI statement</title><p>The authors declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="S13"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd-Elsayed</surname><given-names>A.</given-names></name><name><surname>Stark</surname><given-names>C. W.</given-names></name><name><surname>Topoluk</surname><given-names>N.</given-names></name><name><surname>Isaamullah</surname><given-names>M.</given-names></name><name><surname>Uzodinma</surname><given-names>P.</given-names></name><name><surname>Viswanath</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>A brief review of complex regional pain syndrome and current management.</article-title>
<source><italic>Ann. Med.</italic></source>
<volume>56</volume>:<fpage>2334398</fpage>. <pub-id pub-id-type="doi">10.1080/07853890.2024.2334398</pub-id>
<pub-id pub-id-type="pmid">38569195</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Battat</surname><given-names>M. M.</given-names></name><name><surname>Etoom</surname><given-names>M.</given-names></name><name><surname>Alghwiri</surname><given-names>A. A.</given-names></name></person-group> (<year>2023</year>). <article-title>Relationship between sleep quality and shoulder disorders in people with stroke.</article-title>
<source><italic>Medicina (Kaunas)</italic></source>
<volume>59</volume>:<fpage>2010</fpage>. <pub-id pub-id-type="doi">10.3390/medicina59112010</pub-id>
<pub-id pub-id-type="pmid">38004059</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>P. J.</given-names></name><name><surname>Hines</surname><given-names>S.</given-names></name><name><surname>Eisenberg</surname><given-names>E.</given-names></name><name><surname>Pud</surname><given-names>D.</given-names></name><name><surname>Finlay</surname><given-names>D. R.</given-names></name><name><surname>Connolly</surname><given-names>K. M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome.</article-title>
<source><italic>Pain</italic></source>
<volume>120</volume>
<fpage>244</fpage>&#x02013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2005.10.035</pub-id>
<pub-id pub-id-type="pmid">16427199</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhamzawi</surname><given-names>R.</given-names></name><name><surname>Ali</surname><given-names>H. T. M.</given-names></name></person-group> (<year>2018</year>). <article-title>The Bayesian adaptive lasso regression.</article-title>
<source><italic>Math. Biosci.</italic></source>
<volume>303</volume>
<fpage>75</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.mbs.2018.06.004</pub-id>
<pub-id pub-id-type="pmid">29920251</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atrooz</surname><given-names>F.</given-names></name><name><surname>Salim</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Sleep deprivation, oxidative stress and inflammation.</article-title>
<source><italic>Adv. Protein Chem. Struct. Biol.</italic></source>
<volume>119</volume>
<fpage>309</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apcsb.2019.03.001</pub-id>
<pub-id pub-id-type="pmid">31997771</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balachandran</surname><given-names>V. P.</given-names></name><name><surname>Gonen</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>J. J.</given-names></name><name><surname>DeMatteo</surname><given-names>R. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Nomograms in oncology: More than meets the eye.</article-title>
<source><italic>Lancet Oncol.</italic></source>
<volume>16</volume>
<fpage>e173</fpage>&#x02013;<lpage>e180</lpage>. <pub-id pub-id-type="doi">10.1016/s1470-2045(14)71116-7</pub-id>
<pub-id pub-id-type="pmid">25846097</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchers</surname><given-names>A. T.</given-names></name><name><surname>Gershwin</surname><given-names>M. E.</given-names></name></person-group> (<year>2017</year>). <article-title>The clinical relevance of complex regional pain syndrome type I: The Emperor&#x02019;s new clothes.</article-title>
<source><italic>Autoimmun. Rev.</italic></source>
<volume>16</volume>
<fpage>22</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2016.09.024</pub-id>
<pub-id pub-id-type="pmid">27666818</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruehl</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Complex regional pain syndrome.</article-title>
<source><italic>Bmj</italic></source>
<volume>351</volume>:<fpage>h2730</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.h2730</pub-id>
<pub-id pub-id-type="pmid">26224572</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carcel</surname><given-names>C.</given-names></name><name><surname>Woodward</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Bushnell</surname><given-names>C.</given-names></name><name><surname>Sandset</surname><given-names>E. C.</given-names></name></person-group> (<year>2020</year>). <article-title>Sex matters in stroke: A review of recent evidence on the differences between women and men.</article-title>
<source><italic>Front. Neuroendocrinol.</italic></source>
<volume>59</volume>:<fpage>100870</fpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2020.100870</pub-id>
<pub-id pub-id-type="pmid">32882229</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><collab>Chinese Medical Association Neurology Branch</collab> (<year>2019</year>). <article-title>Diagnostic criteria of cerebrovascular diseases in China (version 2019).</article-title>
<source><italic>Chin. J. Neurol</italic>.</source>
<volume>52</volume>, <fpage>710</fpage>&#x02013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1006-7876.2019.09.003</pub-id>
<pub-id pub-id-type="pmid">30704229</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eldufani</surname><given-names>J.</given-names></name><name><surname>Elahmer</surname><given-names>N.</given-names></name><name><surname>Blaise</surname><given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>A medical mystery of complex regional pain syndrome.</article-title>
<source><italic>Heliyon</italic></source>
<volume>6</volume>:<fpage>e03329</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03329</pub-id>
<pub-id pub-id-type="pmid">32149194</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsamadicy</surname><given-names>A. A.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Sergesketter</surname><given-names>A. R.</given-names></name><name><surname>Ashraf</surname><given-names>B.</given-names></name><name><surname>Charalambous</surname><given-names>L.</given-names></name><name><surname>Kemeny</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Prevalence and cost analysis of complex regional pain syndrome (CRPS): A role for neuromodulation.</article-title>
<source><italic>Neuromodulation</italic></source>
<volume>21</volume>
<fpage>423</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1111/ner.12691</pub-id>
<pub-id pub-id-type="pmid">28961359</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erdo&#x0011f;an</surname><given-names>K.</given-names></name><name><surname>Kara</surname><given-names>M.</given-names></name><name><surname>&#x0015e;ener</surname><given-names>F. E.</given-names></name><name><surname>Durmu&#x0015f;</surname><given-names>M. E.</given-names></name><name><surname>Durmu&#x0015f;o&#x0011f;lu</surname><given-names>B.</given-names></name><name><surname>Abdulsalam</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Serum albumin as a biomarker of (nutritional status in) sarcopenia.</article-title>
<source><italic>J. Bone Miner. Metab.</italic></source>
<volume>43</volume>
<fpage>108</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1007/s00774-024-01557-9</pub-id>
<pub-id pub-id-type="pmid">39516399</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>E. Y.</given-names></name><name><surname>Jung</surname><given-names>H. Y.</given-names></name><name><surname>Kim</surname><given-names>M. O.</given-names></name></person-group> (<year>2014</year>). <article-title>Absent median somatosensory evoked potential is a predictor of type I complex regional pain syndrome after stroke.</article-title>
<source><italic>Disabil. Rehabil.</italic></source>
<volume>36</volume>
<fpage>1080</fpage>&#x02013;<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.3109/09638288.2013.829530</pub-id>
<pub-id pub-id-type="pmid">24050813</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>M. A.</given-names></name><name><surname>Sabeka</surname><given-names>M. M.</given-names></name><name><surname>Miah</surname><given-names>M. B. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Shoulder hand syndrome in hemispheric stroke.</article-title>
<source><italic>J. Neurol. Sci.</italic></source>
<volume>333</volume>:<fpage>e167</fpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2013.07.693</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harden</surname><given-names>R. N.</given-names></name><name><surname>Oaklander</surname><given-names>A. L.</given-names></name><name><surname>Burton</surname><given-names>A. W.</given-names></name><name><surname>Perez</surname><given-names>R. S.</given-names></name><name><surname>Richardson</surname><given-names>K.</given-names></name><name><surname>Swan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Complex regional pain syndrome: Practical diagnostic and treatment guidelines, 4th edition.</article-title>
<source><italic>Pain Med.</italic></source>
<volume>14</volume>
<fpage>180</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1111/pme.12033</pub-id>
<pub-id pub-id-type="pmid">23331950</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>G.</given-names></name><name><surname>Nan</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Prevalence and risk factors of sarcopenia in patients with stroke: A systematic review and meta-analysis.</article-title>
<source><italic>Neurosurg. Rev.</italic></source>
<volume>48</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1007/s10143-024-03143-z</pub-id>
<pub-id pub-id-type="pmid">39729202</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hok</surname><given-names>P.</given-names></name><name><surname>Strauss</surname><given-names>S.</given-names></name><name><surname>McAuley</surname><given-names>J.</given-names></name><name><surname>Domin</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>A. P.</given-names></name><name><surname>Rae</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Functional connectivity in complex regional pain syndrome: A bicentric study.</article-title>
<source><italic>Neuroimage</italic></source>
<volume>301</volume>:<fpage>120886</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2024.120886</pub-id>
<pub-id pub-id-type="pmid">39424016</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Phillips</surname><given-names>B. G.</given-names></name><name><surname>Sigurdsson</surname><given-names>G.</given-names></name><name><surname>Narkiewicz</surname><given-names>K.</given-names></name><name><surname>Pesek</surname><given-names>C. A.</given-names></name><name><surname>Somers</surname><given-names>V. K.</given-names></name></person-group> (<year>2000</year>). <article-title>Effects of sleep deprivation on neural circulatory control.</article-title>
<source><italic>Hypertension</italic></source>
<volume>35</volume>
<fpage>1173</fpage>&#x02013;<lpage>1175</lpage>. <pub-id pub-id-type="doi">10.1161/01.hyp.35.5.1173</pub-id>
<pub-id pub-id-type="pmid">10818083</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsura</surname><given-names>Y.</given-names></name><name><surname>Ohga</surname><given-names>S.</given-names></name><name><surname>Shimo</surname><given-names>K.</given-names></name><name><surname>Hattori</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Matsubara</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>Post-Stroke complex regional pain syndrome and upper limb inactivity in hemiplegic patients: A cross-sectional study.</article-title>
<source><italic>J. Pain Res.</italic></source>
<volume>15</volume>
<fpage>3255</fpage>&#x02013;<lpage>3262</lpage>. <pub-id pub-id-type="doi">10.2147/jpr.S379840</pub-id>
<pub-id pub-id-type="pmid">36281309</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsura</surname><given-names>Y.</given-names></name><name><surname>Ohga</surname><given-names>S.</given-names></name><name><surname>Shimo</surname><given-names>K.</given-names></name><name><surname>Hattori</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Matsubara</surname><given-names>T.</given-names></name></person-group> (<year>2024</year>). <article-title>A decision tree algorithm to identify predictors of post-stroke complex regional pain syndrome.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>14</volume>:<fpage>9893</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-60597-3</pub-id>
<pub-id pub-id-type="pmid">38689114</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Yoon</surname><given-names>S. Y.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Jeong</surname><given-names>Y. H.</given-names></name><name><surname>Kim</surname><given-names>Y. W.</given-names></name></person-group> (<year>2020</year>). <article-title>Neural substrates for poststroke complex regional pain syndrome type I: A retrospective case-control study using voxel-based lesion symptom mapping analysis.</article-title>
<source><italic>Pain</italic></source>
<volume>161</volume>
<fpage>1311</fpage>&#x02013;<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000001816</pub-id>
<pub-id pub-id-type="pmid">31985589</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>I.</given-names></name><name><surname>Hosokawa</surname><given-names>K.</given-names></name><name><surname>Soma</surname><given-names>M.</given-names></name><name><surname>Iwata</surname><given-names>M.</given-names></name><name><surname>Maltais</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Protocol to prevent shoulder-hand syndrome after stroke.</article-title>
<source><italic>Arch. Phys. Med. Rehabil.</italic></source>
<volume>82</volume>
<fpage>1619</fpage>&#x02013;<lpage>1623</lpage>. <pub-id pub-id-type="doi">10.1053/apmr.2001.25975</pub-id>
<pub-id pub-id-type="pmid">11689984</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000fc;&#x000e7;&#x000fc;kdeveci</surname><given-names>A. A.</given-names></name><name><surname>Tennant</surname><given-names>A.</given-names></name><name><surname>Hardo</surname><given-names>P.</given-names></name><name><surname>Chamberlain</surname><given-names>M. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Sleep problems in stroke patients: Relationship with shoulder pain.</article-title>
<source><italic>Clin. Rehabil.</italic></source>
<volume>10</volume>
<fpage>166</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1177/026921559601000214</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinus</surname><given-names>J.</given-names></name><name><surname>Moseley</surname><given-names>G. L.</given-names></name><name><surname>Birklein</surname><given-names>F.</given-names></name><name><surname>Baron</surname><given-names>R.</given-names></name><name><surname>Maih&#x000f6;fner</surname><given-names>C.</given-names></name><name><surname>Kingery</surname><given-names>W. S.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Clinical features and pathophysiology of complex regional pain syndrome.</article-title>
<source><italic>Lancet Neurol.</italic></source>
<volume>10</volume>
<fpage>637</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(11)70106-5</pub-id>
<pub-id pub-id-type="pmid">21683929</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matayoshi</surname><given-names>S.</given-names></name><name><surname>Shimodozono</surname><given-names>M.</given-names></name><name><surname>Hirata</surname><given-names>Y.</given-names></name><name><surname>Ueda</surname><given-names>T.</given-names></name><name><surname>Horio</surname><given-names>S.</given-names></name><name><surname>Kawahira</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Use of calcitonin to prevent complex regional pain syndrome type I in severe hemiplegic patients after stroke.</article-title>
<source><italic>Disabil. Rehabil.</italic></source>
<volume>31</volume>
<fpage>1773</fpage>&#x02013;<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.1080/09638280902795573</pub-id>
<pub-id pub-id-type="pmid">19479511</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Merskey</surname><given-names>H.</given-names></name></person-group>
<role>(ed.)</role> (<year>1986</year>). <source><italic>Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms</italic></source>, <fpage>226</fpage>.</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misidou</surname><given-names>C.</given-names></name><name><surname>Papagoras</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Complex regional pain syndrome: An update.</article-title>
<source><italic>Mediterr. J. Rheumatol.</italic></source>
<volume>30</volume>
<fpage>16</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.31138/mjr.30.1.16</pub-id>
<pub-id pub-id-type="pmid">32185338</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkitny</surname><given-names>L.</given-names></name><name><surname>McAuley</surname><given-names>J. H.</given-names></name><name><surname>Di Pietro</surname><given-names>F.</given-names></name><name><surname>Stanton</surname><given-names>T. R.</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>N. E.</given-names></name><name><surname>Marinus</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Inflammation in complex regional pain syndrome: A systematic review and meta-analysis.</article-title>
<source><italic>Neurology</italic></source>
<volume>80</volume>
<fpage>106</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31827b1aa1</pub-id>
<pub-id pub-id-type="pmid">23267031</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasic</surname><given-names>Z.</given-names></name><name><surname>Smajlovic</surname><given-names>D.</given-names></name><name><surname>Dostovic</surname><given-names>Z.</given-names></name><name><surname>Kojic</surname><given-names>B.</given-names></name><name><surname>Selmanovic</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Incidence and types of sleep disorders in patients with stroke.</article-title>
<source><italic>Med. Arh.</italic></source>
<volume>65</volume>
<fpage>225</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.5455/medarh.2011.65.225-227</pub-id>
<pub-id pub-id-type="pmid">21950229</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauerbrei</surname><given-names>W.</given-names></name><name><surname>Royston</surname><given-names>P.</given-names></name><name><surname>Binder</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Selection of important variables and determination of functional form for continuous predictors in multivariable model building.</article-title>
<source><italic>Stat. Med.</italic></source>
<volume>26</volume>
<fpage>5512</fpage>&#x02013;<lpage>5528</lpage>. <pub-id pub-id-type="doi">10.1002/sim.3148</pub-id>
<pub-id pub-id-type="pmid">18058845</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>S. S.</given-names></name><name><surname>Herman</surname><given-names>M. E.</given-names></name><name><surname>Tun</surname><given-names>M. T. H.</given-names></name><name><surname>Barone</surname><given-names>E.</given-names></name><name><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2024</year>). <article-title>The double life of glucose metabolism: Brain health, glycemic homeostasis, and your patients with type 2 diabetes.</article-title>
<source><italic>BMC Med</italic>.</source>
<volume>22</volume>:<fpage>582</fpage>. <pub-id pub-id-type="doi">10.1186/s12916-024-03763-8</pub-id>
<pub-id pub-id-type="pmid">39696300</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonmez</surname><given-names>I.</given-names></name><name><surname>Karasel</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Poor sleep quality I related to impaired functional status following stroke.</article-title>
<source><italic>J. Stroke Cerebrovasc. Dis.</italic></source>
<volume>28</volume>:<fpage>104349</fpage>. <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2019.104349</pub-id>
<pub-id pub-id-type="pmid">31492629</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbrocker</surname><given-names>O.</given-names></name></person-group> (<year>1947</year>). <article-title>The shoulder-hand syndrome: Associated painful homolateral disability of the shoulder and hand with swelling and atrophy of the hand.</article-title>
<source><italic>Am. J. Med.</italic></source>
<volume>3</volume>
<fpage>402</fpage>&#x02013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9343(47)90170-8</pub-id>
<pub-id pub-id-type="pmid">20264705</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y. C.</given-names></name><name><surname>Guo</surname><given-names>Y. H.</given-names></name><name><surname>Hsieh</surname><given-names>P. C.</given-names></name><name><surname>Lin</surname><given-names>Y. C.</given-names></name></person-group> (<year>2021</year>). <article-title>A meta-analysis and meta-regression of frequency and risk factors for poststroke complex regional pain syndrome.</article-title>
<source><italic>Medicina (Kaunas)</italic></source>
<volume>57</volume>:<fpage>1232</fpage>. <pub-id pub-id-type="doi">10.3390/medicina57111232</pub-id>
<pub-id pub-id-type="pmid">34833449</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S. S.</given-names></name><name><surname>Noor</surname><given-names>N.</given-names></name><name><surname>Urits</surname><given-names>I.</given-names></name><name><surname>Paladini</surname><given-names>A.</given-names></name><name><surname>Sadhu</surname><given-names>M. S.</given-names></name><name><surname>Gibb</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Complex regional pain syndrome: A comprehensive review.</article-title>
<source><italic>Pain Ther.</italic></source>
<volume>10</volume>
<fpage>875</fpage>&#x02013;<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1007/s40122-021-00279-4</pub-id>
<pub-id pub-id-type="pmid">34165690</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobaldini</surname><given-names>E.</given-names></name><name><surname>Costantino</surname><given-names>G.</given-names></name><name><surname>Solbiati</surname><given-names>M.</given-names></name><name><surname>Cogliati</surname><given-names>C.</given-names></name><name><surname>Kara</surname><given-names>T.</given-names></name><name><surname>Nobili</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases.</article-title>
<source><italic>Neurosci. Biobehav. Rev.</italic></source>
<volume>74</volume>
<fpage>321</fpage>&#x02013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.07.004</pub-id>
<pub-id pub-id-type="pmid">27397854</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomata</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>H&#x000e4;gg</surname><given-names>S.</given-names></name><name><surname>Jylh&#x000e4;v&#x000e4;</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Protein nutritional status and frailty: A mendelian randomization study.</article-title>
<source><italic>J. Nutr.</italic></source>
<volume>152</volume>
<fpage>269</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1093/jn/nxab348</pub-id>
<pub-id pub-id-type="pmid">34601600</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urits</surname><given-names>I.</given-names></name><name><surname>Shen</surname><given-names>A. H.</given-names></name><name><surname>Jones</surname><given-names>M. R.</given-names></name><name><surname>Viswanath</surname><given-names>O.</given-names></name><name><surname>Kaye</surname><given-names>A. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Complex regional pain syndrome, current concepts and treatment options.</article-title>
<source><italic>Curr. Pain Headache Rep.</italic></source>
<volume>22</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.1007/s11916-018-0667-7</pub-id>
<pub-id pub-id-type="pmid">29404787</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Velzen</surname><given-names>G. A. J.</given-names></name><name><surname>Huygen</surname><given-names>F.</given-names></name><name><surname>van Kleef</surname><given-names>M.</given-names></name><name><surname>van Eijs</surname><given-names>F. V.</given-names></name><name><surname>Marinus</surname><given-names>J.</given-names></name><name><surname>van Hilten</surname><given-names>J. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Sex matters in complex regional pain syndrome.</article-title>
<source><italic>Eur. J. Pain</italic></source>
<volume>23</volume>
<fpage>1108</fpage>&#x02013;<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1002/ejp.1375</pub-id>
<pub-id pub-id-type="pmid">30735277</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>A. J.</given-names></name><name><surname>Cronin</surname><given-names>A. M.</given-names></name><name><surname>Elkin</surname><given-names>E. B.</given-names></name><name><surname>Gonen</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.</article-title>
<source><italic>BMC Med. Inform. Decis. Mak.</italic></source>
<volume>8</volume>:<fpage>53</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6947-8-53</pub-id>
<pub-id pub-id-type="pmid">19036144</pub-id>
</mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Hang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name></person-group> (<year>2025</year>). <article-title>Associations of inflammatory markers with neurological dysfunction and prognosis in patients with progressive stroke.</article-title>
<source><italic>Eur. J. Neurol.</italic></source>
<volume>32</volume>:<fpage>e70080</fpage>. <pub-id pub-id-type="doi">10.1111/ene.70080</pub-id>
<pub-id pub-id-type="pmid">39957269</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>A predictive model based on random forest for shoulder-hand syndrome.</article-title>
<source><italic>Front. Neurosci.</italic></source>
<volume>17</volume>:<fpage>1124329</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2023.1124329</pub-id>
<pub-id pub-id-type="pmid">37065924</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Risk factors of the post-stroke shoulder-hand syndrome.</article-title>
<source><italic>Chinese J. Neurol.</italic></source>
<volume>37</volume>, <fpage>27</fpage>&#x02013;<lpage>29</lpage>.</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Relationship between sleep disorders and the prognosis of neurological function after stroke.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>13</volume>:<fpage>1036980</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2022.1036980</pub-id>
<pub-id pub-id-type="pmid">36388217</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorowitz</surname><given-names>R. D.</given-names></name><name><surname>Hughes</surname><given-names>M. B.</given-names></name><name><surname>Idank</surname><given-names>D.</given-names></name><name><surname>Ikai</surname><given-names>T.</given-names></name><name><surname>Johnston</surname><given-names>M. V.</given-names></name></person-group> (<year>1996</year>). <article-title>Shoulder pain and subluxation after stroke: Correlation or coincidence?</article-title>
<source><italic>Am. J. Occup. Ther.</italic></source>
<volume>50</volume>
<fpage>194</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.5014/ajot.50.3.194</pub-id>
<pub-id pub-id-type="pmid">8822242</pub-id>
</mixed-citation></ref></ref-list></back></article>